Drug Information

Drug General Information
Drug ID
D06BNI
Former ID
DNC011512
Drug Name
(9H-beta-Carbolin-3-yl)-methanol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [533414]
Formula
C12H10N2O
Canonical SMILES
C1=CC=C2C(=C1)C3=CC(=NC=C3N2)CO
InChI
1S/C12H10N2O/c15-7-8-5-10-9-3-1-2-4-11(9)14-12(10)6-13-8/h1-6,14-15H,7H2
InChIKey
CPBYHTDUBNSBQM-UHFFFAOYSA-N
PubChem Compound ID
5353338
Target and Pathway
Target(s) Gamma-aminobutyric acid receptor subunit alpha-1 Target Info Inhibitor [533414]
Gamma-aminobutyric acid receptor Target Info Inhibitor [533414]
KEGG Pathway Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
GABAergic synapse
Morphine addiction
Nicotine addiction
Reactome Ligand-gated ion channel transport
GABA A receptor activation
WikiPathways SIDS Susceptibility Pathways
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
Iron uptake and transport
References
Ref 533414J Med Chem. 1987 Apr;30(4):750-3.Synthesis of 6-substituted beta-carbolines that behave as benzodiazepine receptor antagonists or inverse agonists.
Ref 533414J Med Chem. 1987 Apr;30(4):750-3.Synthesis of 6-substituted beta-carbolines that behave as benzodiazepine receptor antagonists or inverse agonists.